These sales are routine tax- and liquidity-driven dispositions following option exercises. No bearish signal, ignore. Monitor next 10-Q for any fundamental changes, but this cluster has no trading implications.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 8 $544.69entry
- T+1 · 5mo ago +1.55%α +1.84% · $553.14
- T+5 · 5mo ago +0.90%α −1.22% · $549.57
- T+20 · 4mo ago +0.47%α −1.16% · $547.25
- T+60 · 3mo ago −6.30%α −9.36% · $510.35
Price Chart
How similar events traded
Executive Summary
Three top insiders at United Therapeutics (CEO, CFO, General Counsel) sold a total of $391K in open-market shares over a 2-day period (June 3-4, 2026). These sales are trivial relative to the $23.2B market cap (0.0017%), are part of a broader cluster of option exercises and same-day sales that appear to be tax- and liquidity-driven, and carry no material informational signal.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 401 shares for ~$218K on June 3, 2026
- EVP & General Counsel Paul Mahon sold 200 shares for ~$108K on June 4, 2026
- CFO James Edgemond sold 120 shares for ~$65K on June 4, 2026
- Total open-market sales: $391K, representing 0.0017% of $23.2B market cap
- All three insiders concurrently exercised large option tranches (CEO: 28,500 shares; CFO: 20,000 shares; GC: 8,300 shares), sales are clearly tax-cover and liquidity-driven
- No insider open-market purchases in the cluster
Financial Impact
Total insider sales of $391K are negligible relative to $23.2B market cap (0.0017%)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1780691656614 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers